US · Healthcare · Drug Manufacturers - General
EPS came in at -1.28 against a street estimate of -1.47 — a beat of 12.9%.
Analysts rate Merck & Company Inc a buy (15 buy, 11 hold, 0 sell out of 26) with an average price target of $135.19.
| Fund | Stake |
|---|---|
| BlackRock Inc | 9.14% |
| Vanguard Capital Management, LLC | 6.52% |
| State Street Corp | 4.83% |
| Wellington Management Company LLP | 3.41% |
| Vanguard Portfolio Management, LLC | 2.73% |
| Geode Capital Management, LLC | 2.41% |
| JPMorgan Chase & Co | 2.14% |
| Charles Schwab Investment Management Inc | 2.01% |
| Document | Date |
|---|---|
| Shareholder vote results · Q2 2026 | 2026-05-28 |
| Company announcement · Q2 2026 | 2026-05-22 |
| Quarterly report · Q1 2026 | 2026-05-04 |
| Results announced · Q2 2026 | 2026-04-30 |
| Proxy statement · Q2 2026 | 2026-04-08 |
| Annual report FY2025 | 2026-02-24 |
| Results announced · Q1 2026 | 2026-02-03 |
| Quarterly report · Q3 2025 | 2025-11-05 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.85 / share ex-date Sep 15, 2026 · pay Oct 7, 2026 | 2026-09-15 |
| Dividend | $0.85 / share ex-date Jun 15, 2026 · pay Jul 8, 2026 | 2026-06-15 |
| Dividend | $0.85 / share ex-date Mar 16, 2026 · pay Apr 7, 2026 | 2026-03-16 |
| Dividend | $0.85 / share ex-date Dec 15, 2025 · pay Jan 8, 2026 | 2025-12-15 |
| Dividend | $0.81 / share ex-date Sep 15, 2025 · pay Oct 7, 2025 | 2025-09-15 |
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Merck & Company Inc — free to start.
Google PlayApp StoreData updated 2026-08-05.